PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients

• Päätekijät: Xu Liu (Tekijä), Ling Song (Tekijä), Yuanhui Zhang (Tekijä), Haiyan Li (Tekijä), Cheng Cui (Tekijä), Dongyang Liu (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2023-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objective: PB-119, a PEGylated exenatide injection, is a once-weekly glucagon-like peptide-1 receptor agonist. In the present study, we aimed to evaluate the effects of PB-119 on insulin resistance and beta-cell function in Chinese patients with type 2 diabetes mellitus (T2DM) to uncover its antidia...